SOCIETY ON SARCOPENIA, CACHEXIA, & WASTING DISORDERS (SCWD)
The Leading International Conference on Cachexia, Sarcopenia & Muscle Wasting
Join clinicians, researchers and experts advancing the science of muscle wasting disorders. Over 400 clinicians and researchers from 45+ countries attend SCWD each year
- 📍 Washington, DC •
- December 10–12, 2026
From Basic Science to Clinical Management of Sarcopenia, Cachexia and Wasting
Multidisciplinary Approaches to Improve Patients’ Outcomes
The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD) focuses on muscle wasting across a number of medical conditions and strives to enhance global health by advancing cutting-edge research that informs effective policies and practices for medical professionals and healthcare stakeholders.
Our mission is to address the challenges of cachexia (including cancer cachexia), sarcopenia, and wasting disorders involving all stakeholders to improve the lives of patients with cachexia and sarcopenia worldwide.
Explore the latest programs and information about Sarcopenia, Cachexia, & Wasting Disorders
Stay Involved
SCIENCE & RESEARCH
Your Area of Expertise
Explore our Programs and Resources
- 🗓️ Date: 2026-06-10
- 📰 Journal: Molecular Metabolism
- 🗓️ Date: 2026-06-09
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-06-08
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2026-06-08
- 📰 Journal: Liver International
- 🗓️ Date: 2026-06-08
- 📰 Journal: Journal Of Gastroenterology
- 🗓️ Date: 2026-06-08
- 📰 Journal: Revista Medica De Chile
- 🗓️ Date: 2026-06-07
- 📰 Journal: Clinical Nutrition
- 🗓️ Date: 2026-06-04
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
PEBP4 alleviates muscle wasting in lung cancer cachexia via KEAP1-NRF2-mediated redox homeostasis.
Exercise training prior to and during cancer in mice preserves muscle mass, reduces tumour weight and suppresses molecular mediators of cachexia.
Combined GLIM-defined malnutrition and sarcopenia and the risk of 2-year mortality in adults with heart failure: A FRAGILE-HF study post hoc analysis.
Prognostic impact of weight loss during first-line chemotherapy in extensive-disease small cell lung cancer.
Our Dedication to Advancing Science
The Journal of Cachexia, Sarcopenia and Muscle is committed to pioneering research that addresses the critical challenges of cachexia and sarcopenia. By publishing the finest work from across the life sciences, we unite experts to push the boundaries of knowledge and improve patient care. Discover how our journal can support your research through opportunities for publication and collaboration.
Register Now!
Embrace this opportunity to redefine the field and create lasting impact in the lives of patients worldwide.
